JP2006513135A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513135A5 JP2006513135A5 JP2004513330A JP2004513330A JP2006513135A5 JP 2006513135 A5 JP2006513135 A5 JP 2006513135A5 JP 2004513330 A JP2004513330 A JP 2004513330A JP 2004513330 A JP2004513330 A JP 2004513330A JP 2006513135 A5 JP2006513135 A5 JP 2006513135A5
- Authority
- JP
- Japan
- Prior art keywords
- aurora
- screening
- protein
- hybridoma
- monoclonal antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004408 hybridoma Anatomy 0.000 claims description 35
- 238000012216 screening Methods 0.000 claims description 32
- 210000004027 cell Anatomy 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 12
- 238000001114 immunoprecipitation Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 241000699670 Mus sp. Species 0.000 claims description 9
- 101100325641 Mus musculus Aurka gene Proteins 0.000 claims description 8
- 108090000144 Human Proteins Proteins 0.000 claims description 6
- 210000003793 centrosome Anatomy 0.000 claims description 6
- 238000010166 immunofluorescence Methods 0.000 claims description 6
- 102000001253 Protein Kinase Human genes 0.000 claims description 4
- 108060006633 protein kinase Proteins 0.000 claims description 4
- 241000699800 Cricetinae Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 238000010367 cloning Methods 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 3
- 210000005260 human cell Anatomy 0.000 claims description 3
- 238000002649 immunization Methods 0.000 claims description 3
- 230000003053 immunization Effects 0.000 claims description 3
- 210000004989 spleen cell Anatomy 0.000 claims description 3
- 101000798300 Homo sapiens Aurora kinase A Proteins 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000010186 staining Methods 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 239000012472 biological sample Substances 0.000 claims 4
- 108090000461 Aurora Kinase A Proteins 0.000 claims 3
- 102000004000 Aurora Kinase A Human genes 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- 108050006400 Cyclin Proteins 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 102000009339 Proliferating Cell Nuclear Antigen Human genes 0.000 claims 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 2
- 230000004663 cell proliferation Effects 0.000 claims 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 206010017758 gastric cancer Diseases 0.000 claims 2
- 238000004393 prognosis Methods 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003550 marker Substances 0.000 claims 1
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 238000010837 poor prognosis Methods 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000012474 protein marker Substances 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0207212A FR2840905B1 (fr) | 2002-06-12 | 2002-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
| PCT/FR2003/001772 WO2003106500A1 (fr) | 2002-06-12 | 2003-06-12 | Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006513135A JP2006513135A (ja) | 2006-04-20 |
| JP2006513135A5 true JP2006513135A5 (enExample) | 2006-06-29 |
| JP4555681B2 JP4555681B2 (ja) | 2010-10-06 |
Family
ID=29595167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004513330A Expired - Lifetime JP4555681B2 (ja) | 2002-06-12 | 2003-06-12 | 抗オーロラ−ａモノクローナル抗体、該抗体を得る方法、並びに癌の診断および処置のための該抗体の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7514231B2 (enExample) |
| EP (1) | EP1511771B1 (enExample) |
| JP (1) | JP4555681B2 (enExample) |
| AT (1) | ATE420115T1 (enExample) |
| AU (1) | AU2003255671A1 (enExample) |
| CA (1) | CA2489214C (enExample) |
| DE (1) | DE60325725D1 (enExample) |
| FR (1) | FR2840905B1 (enExample) |
| WO (1) | WO2003106500A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1694686A1 (en) | 2003-12-19 | 2006-08-30 | Takeda San Diego, Inc. | Kinase inhibitors |
| JP2008510734A (ja) | 2004-08-18 | 2008-04-10 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
| EP1812439B2 (en) | 2004-10-15 | 2017-12-06 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| JP2010505962A (ja) | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2239692C (en) * | 1995-12-18 | 2008-12-16 | Sugen, Inc. | Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
-
2002
- 2002-06-12 FR FR0207212A patent/FR2840905B1/fr not_active Expired - Lifetime
-
2003
- 2003-06-12 AU AU2003255671A patent/AU2003255671A1/en not_active Abandoned
- 2003-06-12 US US10/517,645 patent/US7514231B2/en not_active Expired - Lifetime
- 2003-06-12 WO PCT/FR2003/001772 patent/WO2003106500A1/fr not_active Ceased
- 2003-06-12 CA CA2489214A patent/CA2489214C/fr not_active Expired - Lifetime
- 2003-06-12 DE DE60325725T patent/DE60325725D1/de not_active Expired - Lifetime
- 2003-06-12 EP EP03760023A patent/EP1511771B1/fr not_active Expired - Lifetime
- 2003-06-12 AT AT03760023T patent/ATE420115T1/de not_active IP Right Cessation
- 2003-06-12 JP JP2004513330A patent/JP4555681B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5524276B2 (ja) | 食道ガンを検出するための組成物及び方法 | |
| WO2014017491A1 (ja) | Ｃｅｐ５５遺伝子とｒｅｔ遺伝子との融合遺伝子 | |
| JP2001512314A (ja) | 肺癌用のタンパク質マーカーおよびその使用 | |
| Carramolino et al. | SA-1, a nuclear protein encoded by one member of a novel gene family: molecular cloning and detection in hemopoietic organs | |
| AU743300B2 (en) | Proteome analysis for characterization of up- and down-regulated proteins in biological samples | |
| CN104422763A (zh) | 抗原组在制备诊断疾病的试剂盒中的用途和试剂盒 | |
| TWI292824B (en) | Agent for detecting metastatic potential of cancer cell | |
| WO2017073619A1 (ja) | 悪性リンパ腫又は白血病の罹患の有無の判別方法並びに白血病の治療及び／又は予防のための薬剤 | |
| US20140005365A1 (en) | Antibody to a mutant g-csf for diagnosis of cancer | |
| JP2006513135A5 (enExample) | ||
| CN1721554B (zh) | 试验肿瘤细胞对于抗癌药剂敏感性的方法 | |
| JPH03505250A (ja) | 体液および組織におけるｒａｓタンパクの検出、定量および分類 | |
| JP4555681B2 (ja) | 抗オーロラ−ａモノクローナル抗体、該抗体を得る方法、並びに癌の診断および処置のための該抗体の使用 | |
| JP4576168B2 (ja) | 膀胱尿管逆流症または間質性膀胱炎の検査方法 | |
| JP3144905B2 (ja) | シナプトフィジンに対する新規なモノクローナル抗体 | |
| JP2007185127A (ja) | 中枢神経系原発悪性リンパ腫マーカーおよびその用途 | |
| CN113528656B (zh) | 评价胶质瘤和/或胃腺癌预后性的试剂盒和系统 | |
| JPH0759588A (ja) | 増殖因子レセプターに対するモノクローナル抗体の製造方法及び抗ｃ−ｅｒｂＢ−２モノクローナル抗体 | |
| JP4712692B2 (ja) | 癌の診断と治療において有用な新規ポリペプチド | |
| JPWO2007037538A1 (ja) | Ｓｐｏ１１遺伝子の治療的又は診断的用途 | |
| JP2008259426A (ja) | 前癌状態から癌への悪性化の過程で発現量が変化する遺伝子の利用 | |
| MXPA00007943A (en) | Methods and compositions for diagnosis of hepatoma | |
| JP2010166873A (ja) | Ｐｏｍｐ遺伝子およびｐｓｍａ７遺伝子の治療的又は診断的用途 | |
| WO2007037550A9 (ja) | Ｔｓｔａ３遺伝子の治療的又は診断的用途 | |
| JP2008259424A (ja) | 前癌状態から癌への悪性化の過程で発現量が変化する遺伝子の利用 |